BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Drug Development

  New Research From the Trudeau Institute Holds Promise for Cancer Immunotherapy Treatments

  July 30, 2012

   · 

  1 min read
• NanoPass Secures Series B Investment to Accelerate Commercialization of its Intradermal Delivery Products

  July 30, 2012

   · 

  3 min read
• Business

  Rochester Medical Reports Third Quarter Results

  July 30, 2012

   · 

  6 min read
• Policy

  Furiex Pharmaceuticals, Inc. Confirms Takeda Pharmaceutical Co. Ltd.'s Resubmissions of Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone NDAs to the FDA

  July 30, 2012

   · 

  1 min read
• Drug Development

  Advaxis, Inc. Reports Updated Phase 2 Cervical Cancer Trial Data at NCI/GOG Meeting

  July 30, 2012

   · 

  1 min read
• Business

  Uroplasty, Inc. Reports Fiscal First Quarter 2013 Financial Results

  July 30, 2012

   · 

  5 min read
• Bio NC

  SalutarisMD Presents Dosimetry Data for Promising Device to Treat Leading Cause of Blindness at AAPM Annual Meeting

  July 30, 2012

   · 

  1 min read
• Business

  Compugen Ltd. Second Quarter 2012 Conference Call Scheduled for Tuesday, August 7, 2012 at 10:00 AM EDT

  July 30, 2012

   · 

  1 min read
• Genetown

  Sunovion Pharmaceuticals Inc. Announces Nationwide Availability of ZETONNA™ (ciclesonide) Nasal Aerosol for Allergic Rhinitis

  July 30, 2012

   · 

  1 min read
• Business

  Solta Medical, Inc. Reports Second Quarter Results

  July 30, 2012

   · 

  7 min read